Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Neurodevelopmental disorders and anti-epileptic treatment in a patient with a SATB1 mutation: A case report

Autor: Ying Yu, Cuiyun Li, Wei Li, Liting Chen, Dan Wang, Jie Wang, Jian Wang, Ruen Yao

Publikováno v: Frontiers in Pediatrics, Vol 10 (2022)

SATB1 variants causing developmental delay with dysmorphic facies and dental anomalies have been reported in a small cohort. Most patients present epilepsy as a main clinical feature in neurodevelopmental disorders; however, its treatment is unknown.

Externí odkaz: https://doaj.org/article/6695d2e8527e49039acdfdad2da4fecd

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.

Autor: Mandro, Michel¹ (AUTHOR), Siewe Fodjo, Joseph Nelson² (AUTHOR), Mukendi, Deby³ (AUTHOR), Dusabimana, Alfred² (AUTHOR), Menon, Sonia² (AUTHOR), Haesendonckx, Steven⁴ (AUTHOR), Lokonda, Richard³ (AUTHOR), Nakato, Swabra² (AUTHOR), Nyisi, Francoise⁵ (AUTHOR), Abhafule, Germain⁵ (AUTHOR), Wonya'Rossi, Deogratias⁶ (AUTHOR), Jakwong, Jean Marie⁷ (AUTHOR), Suykerbuyk, Patrick² (AUTHOR), Meganck, Jacques² (AUTHOR), Hotterbeekx, An² (AUTHOR), Colebunders, Robert² (AUTHOR) robert.colebunders@uantwerpen.be

Publikováno v: PLoS Neglected Tropical Diseases. 1/10/2020, Vol. 14 Issue 1, p1-16. 16p.

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.

Autor: Michel Mandro, Joseph Nelson Siewe Fodjo, Deby Mukendi, Alfred Dusabimana, Sonia Menon, Steven Haesendonckx, Richard Lokonda, Swabra Nakato, Francoise Nyisi, Germain Abhafule, Deogratias Wonya'Rossi, Jean Marie Jakwong, Patrick Suykerbuyk, Jacques Meganck, An Hotterbeekx, Robert Colebunders

Publikováno v: PLoS Neglected Tropical Diseases, Vol 14, Iss 1, p e0007966 (2020)

INTRODUCTION:Recent findings from onchocerciasis-endemic foci uphold that increasing ivermectin coverage reduces the epilepsy incidence, and anecdotal evidence suggests seizure frequency reduction in persons with onchocerciasis-associated epilepsy, w

Externí odkaz: https://doaj.org/article/577599405307437ea164259e56940717

THE EFFICACY OF ANTI-EPILEPTIC TREATMENT IN ADULTS BEFORE AND AFTER ITS CORRECTION BY EPILEPTOLOGIST

Autor: P. N. Vlasov, N. V. Orekhova

Publikováno v: Эпилепсия и пароксизмальные состояния, Vol 2, Iss 3, Pp 6-11 (2016)

A comparison was made between the efficacy of anti-epileptic (AE) outpatient treatment which was initially prescribed by neurologist, and that after therapy correction by qualified epileptologist. The prospective study enrolled 310 subjects (69.03% o

Externí odkaz: https://doaj.org/article/91cc02afbc214c86ae770950db267ab0